|
Market Closed -
NSE India S.E.
07:05:07 2026-09-04 am EDT
|
5-day change | 1st Jan Change | ||
| 1,385.00 INR | -0.70% |
|
-2.70% | -8.36% |
| Sep. 03 | India's Cipla, China's Qilu partner for US launch of Merck's Keytruda biosimilar | RE |
| Aug. 25 | Cipla's Pithampur, India Unit Gets 7 Observations From US FDA | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Generic Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 11.85B | |||||
| 48.26B | |||||
| 40.5B | |||||
| 11.83B | |||||
| 9.36B | |||||
| 7.37B |
- Stock Market
- Stocks
- CIPLA Stock
- Charts Cipla Limited
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
